Diamonds and Dogs


No sales, no earnings, no problem. Virgin Galactic (SPCE) jumped 23% today on 7 times normal volume ahead of a present at the Barclays Industrial Select Conference tomorrow. The Richard Branson's company, which promises to ferry tourists to the edge of space and back, is up about 200% year to date even though there are no sales and hence no profits yet. The company reports earnings next week. Should be a short report.

Bluebird Bio (BLUE) was blue today. The stock fell 8.67% after missing expectations for the fourth quarter as sales fell 47.9% to just $10 million. The company ended the year with $1.24 billion cash position, down from $1.89 billion at the prior year-end. Blue expects to treat its first commercial ZYNTEGLO patient in Germany in the first half of 2020. The company has also initiated its rolling BLA submission of LentiGlobin for ß-thalassemia in the US and is engaged in discussions about it with the FDA, including pertaining information regarding various release assays. Raymond James downgraded the stock.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.